Increased ADAM-15 mRNA and protein has been noted in lung, prostate, and breast cancer, and overexpression in breast cancer is coincidental with Her2/neu expression and a more aggressive and invasive phenotype [10,11,12]. Here, ERBB2 is linked to breast carcinoma.